Our Team

Donna Tuths CEO of Perthera Headshot

Donna Tuths

President & CEO


Donna Tuths has more than 20 years’ experience driving growth in healthcare technology. As a founder of Accenture Interactive and Cognizant Digital, Ms. Tuths led the acquisition and integration of more than 15 start up and growth tech companies. She has a solid track record scaling businesses to $1B plus in value. She was both Chief Innovation Officer and Chief Marketing Officer at privately held Sutherland, a key player in AI-driven healthcare customer support services and was a Managing Director at Accenture Life Sciences. As the former CEO of Ogilvy Health, she scaled the business from 4 offices in the US to 44 offices in 33 countries. Ms. Tuths is a recipient of the prestigious Manny Award, in recognition of her contributions to medical marketing by Med Ad News.

Emanuel “Chip” Petricoin, PhD

Chief Science Officer

George Mason University Professor, School Of Systems Biology Co-Director, Center For Applied Proteomics And Molecular Medicine.

Gautam Priya

Chief Technology Officer

Gautam is an engineering leader with expertise in cloud-native architectures and machine learning, known for delivering innovative solutions across healthcare, eCommerce, and logistics.

Jeanne M Cummins - Chief Marketing Officer for Perthera

Jeanne M. Cummins

Chief Marketing Officer

A marketing leader with over 25 years experience in strategy, market intelligence, and professional/B2B marketing.

Derek Raghavan, MD, PhD

Chief Medical Officer

Chief Medical Officer, Perthera; Attending Medical Oncologist at Veterans Administration Health Care Center; Associate Editor, JCO Journal of Oncology Practice.

Michael Pishvaian, MD, PhD

Chief Medical Advisor

Oncologist And Director Of Clinical Research Programs for Johns Hopkins Kimmel Cancer Center.

Senait Fesseha

VP of Finance

20+ years of experience in financial analytics and business operations with a focus on operational efficiency and quality.

Edik Blais, PhD

VP of Research

Biomedical Engineer with expertise in cancer biology, biostatistics and data science.

Brant Adornato

VP of Commercial Operations

Commercial executive with 20+ years experience launching and building successful commercial teams in the medical device, biopharma and molecular laboratory space, from start-up phase through successful IPO and $1B value.

Dzung Thach

Director of Computational Biology

Dzung Thach is a Computational Biologist with extensive experience in Bioinformatics. He earned his PhD in molecular microbiology and immunology from the Johns Hopkins School of Public Health in Baltimore, MD, and BS degree in biology from Virginia Tech. 

Donna Tuths CEO of Perthera Headshot

Donna Tuths

Board Chairperson


Donna Tuths has more than 20 years’ experience driving growth in healthcare technology. As a founder of Accenture Interactive and Cognizant Digital, Ms. Tuths led the acquisition and integration of more than 15 start up and growth tech companies. She has a solid track record scaling businesses to $1B plus in value. She was both Chief Innovation Officer and Chief Marketing Officer at privately held Sutherland, a key player in AI-driven healthcare customer support services and was a Managing Director at Accenture Life Sciences. As the former CEO of Ogilvy Health, she scaled the business from 4 offices in the US to 44 offices in 33 countries. Ms. Tuths is a recipient of the prestigious Manny Award, in recognition of her contributions to medical marketing by Med Ad News.

Margot P. Schoenborn

Board Observer

Margot Schoenborn is Vice President, Head of Oncology Strategy & Business Management for Laboratory Corporation of America Holdings (“Labcorp”) (NYSE:LH), and S&P 500 company headquartered in Burlington, North Carolina. Margot is responsible for driving the oncology strategy across drug development and diagnostic segments and manages the precision medicine drug development sales and client services teams. Margot joined Labcorp in July 2021 through its acquisition of OmniSeq, Inc., where she served as Chief Executive Officer and Board Director from May 2019 through July 2021. Margot was part of the Roswell Park Comprehensive Cancer Center team, where she served as Deputy General Counsel, that spun out OmniSeq in 2015, and held roles as OmniSeq’s CAO & General Counsel from 2015 through her appointment as CEO of OmniSeq in 2019 after OmniSeq secured its Series B funding. Margot continued as VP, Head of OmniSeq through December 2022 when OmniSeq was fully integrated into Labcorp. Margot is a seasoned business executive and attorney with experience in corporate development, transactions, capital market activities, corporate finance, and leadership of multi-functional teams over 20+ year career in healthcare, state and federal healthcare law enforcement, and commercial litigation. Margot received her JD, cum laude, from University at Buffalo School of Law, where she served as Editor in Chief of the Human Rights Law Review. Margot received her bachelor degree cum laude from Nazareth College. Margot lives in Buffalo, New York with her husband, Jeff, and their two boys.

Nan Hayworth, MD

Board Member

Dr. Nan Hayworth is a Business Development Advisor with Pilot Growth Equity, and a Consulting Medical Director in healthcare communications and special projects for The Kinetix Group. She graduated from Princeton University with an A.B. in biology. She then studied at Cornell University Medical College, after which she trained in ophthalmology at Mount Sinai Hospital, New York. Nan practiced ophthalmology for 16 years in Mount Kisco, New York, growing her own solo practice for several years before being a partner in the Mount Kisco Medical Group (now CareMount Medical). She has been honored by being made an Assistant Clinical Professor at Mount Sinai Hospital as well as by being named to many “Best Doctors” lists. She then went on to serve as a vice president and medical director at Cline Davis & Mann, a healthcare communications agency in New York, and a division of Omnicom, where her client was Genentech. Nan is the only woman physician in history to be elected a voting Member of the House of Representatives, serving the 19th District of New York in the 112th Congress.

Yehuda Neuberger

Board Member

Yehuda Neuberger is the President of Brownstone Recovery Group. Neuberger is an active private equity investor with investments in a range of companies in various sectors including financial services, back office processing, and business software. Neuberger serves on the boards of directors for many companies and not-for-profit institutions, including publicly-held Maiden Holdings. From 2001 to 2008, Neuberger was Executive Vice President of American Stock Transfer & Trust Company, and continues to serve on its board and on the board of its international parent, Armor Holdco. Prior to that, Neuberger was an attorney with the firm of Weil, Gotshal & Manges, LLP. Neuberger is a graduate of Johns Hopkins University and Harvard Law School.

Alex Perchuk

Board Member

Alex Perchuk is a highly accomplished and respected leader in the pharmacy industry, with over 37 years of experience in pharmacy operations, logistics, and infrastructure. He graduated with a Bachelor of Science in Pharmacy in 1987 from the Arnold & Marie Schwartz College of Pharmacy & Health Sciences of Long Island University. Since 1988, Alex has held the position of Director of Pharmacy at Thriftway Pharmacy, a group of independent pharmacies in the metropolitan New York area.

Alex’s expertise extends beyond pharmacy, as he possesses a deep understanding of primary medical care and urgent care space. His entrepreneurial spirit and business acumen have been instrumental in running successful and profitable ventures. As a subject matter expert and a savvy businessman, Alex brings a unique perspective to the table.

Throughout his career, Alex has been actively involved in various professional pharmacy organizations, including serving as the vice president of the Arnold & Marie Schwartz College of Pharmacy Alumni Association. He has also given back to his alma mater by establishing a scholarship fund to support aspiring pharmacy students. Additionally, Alex serves on the college’s Admissions Committee, helping to screen potential pharmacy student candidates.

Alex’s leadership roles extend to his position as a former board member of Cardinal Health Retail Advisory Board and his current role as a board member of PSSNY (Pharmacists Society of State of New York). Previously, he held the position of President and Chairman of NYCPS (New York City Pharmacists Society), the largest affiliate chapter of PSSNY. Alex firmly believes in the power of collaborations and relationship building as key components of success.

Neil Callahan

Board Member

Neil Callahan is a Founder and Managing Partner at Pilot Growth Equity and is based in New York City. Neil has over 25 years of technology investing and operating experience and is a successful bootstrapped software entrepreneur. He has advised many of the world’s leading technology companies on strategy, product management, sales & marketing, infrastructure and operations. Neil serves on the boards of Perthera, r4 Technologies and Velocidi and his other active investments include Bizzabo (board observer), CB Insights, Counsyl, Metabiota and Webgility. Neil’s previous investments include Zenedge (acquired by Oracle) and C-Legal (acquired by Ernst & Young).

James “Sandy” Winnefeld, Jr.

Scientific Advisor

John L. Marshall, MD

Scientific Advisor

Jonathan Brody, Ph. D.

Scientific Advisor

THIS IS AI-POWERED PRECISION ONCOLOGY

Contact Us